4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001415889-25-011290
CHIEF EXECUTIVE OFFICER sold 2,804 shares at $48.74 ($136,656)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klein Matthew B. CHIEF EXECUTIVE OFFICER | 2025-04-22 | Sale 10b5-1 | −2,804 | $48.74 | $136,656 | 273,234 | D |
| Open-market sales · 2,804 sh · avg $48.74 · $136,656 | |||||||
Loading xslF345X05/form4-04242025_050401.xml…